Rethinking the PSA Prostate Screening Test
Interview: Andrew Vickers, PhD, researcher, Memorial Sloan-Kettering Cancer Center, New York
One medical trend weíve been following this year has been the questions raised about the value of some forms of routine cancer screening.
Today, we begin with one of those controversies:
The PSA blood test, which has become part of the annual physical for many men over 50, to look for signs of prostate cancer.
The problem with PSA test is that it canít reveal whether a cancer is fast-growing and dangerous or slow-growing and harmless.
Sound Medicineís Dr. David Crabb speaks with the author of a recent study to find which men the PSA test might benefit the most.
Dr. Crabb's guest, Dr. Andrew Vickers, is a researcher at Memorial Sloan-Kettering Cancer Center in New York. He says itís time to re-think the routine PSA test.